|
|
|
Review
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massacusetts 02139, USA
| Abstract |
|---|
|
|
|---|
[Keywords: Sir2; aging; glutamate dehydrogenase; SIRT17; mitochondria; insulin; calorie restriction]
Although a link between Sir2 and longevity was clear, its enzymatic activity remained elusive for years. An early clue came from the observation that CobB, an Escherichia coli homolog of Sir2, could catalyze the phosphoribosyltransferase reaction in cobalamin biosynthesis (Tsang and Escalante-Semerena 1998
). Thus, it was predicted and demonstrated that Sir2 possessed NAD-dependent ADP-ribosyltransferase activity (Frye 1999
; Tanny et al. 1999
). Subsequent reports revealed that yeast and mammalian sirtuins catalyze a novel and robust reaction, NAD-dependent histone deacetylation, unavoidably linking Sir2 activity with metabolism (Imai et al. 2000
; Landry et al. 2000
; Smith et al. 2000
). Mechanistically, ADP-ribosylation and deacetylation reactions by sirtuins are similar because they cleave NAD in each reaction cycle (Fig. 1) (Grubisha et al. 2005
). During each cycle, deacetylation generates the novel metabolites, 2' and 3'-O-acetyl-ADP-ribose (Tanner et al. 2000
; Sauve et al. 2001
; Tanny and Moazed 2001
), which may be important regulators of physiology (Grubisha et al. 2006
). Today, more than a dozen nonhistone deacetylation substrates are known, several of which are described below.
|
Do sirtuins regulate human longevity? Mammals have seven Sir2 homologs (sirtuins, SIRT17). These proteins have a highly conserved NAD-dependent sirtuin core domain, first identified in the founding yeast SIR2 protein, making them good candidates as lifespan regulators (Frye 2000
). As highlighted in this review, mammalian sirtuins have diverse cellular locations, target multiple substrates, and affect a broad range of cellular functions (Table 1). In this review, we emphasize an emerging theme in the field of agingthe regulation of oxidative stress, DNA damage, and metabolism by mammalian sirtuins.
|
| Nuclear sirtuins |
|---|
|
|
|---|
| SIRT1 substrates in mammals |
|---|
|
|
|---|
B, and forkhead proteins to affect stress resistance in cells (Luo et al. 2001
and PGC-
(see below) to influence differentiation of muscle cells, adipogenesis, fat storage in white adipose tissue, and metabolism in the liver, suggesting a possible connection between this sirtuin and diets that promote leanness and longevity (Fulco et al. 2003
|
| SIRT1 regulation of insulin and glucose homeostasis |
|---|
|
|
|---|
Two recent studies in mice have demonstrated that SIRT1 positively regulates glucose-stimulated insulin secretion in pancreatic ß-cells (Moynihan et al. 2005
; Bordone et al. 2006
). ß-Cell-specific SIRT1-overexpressing (BESTO) mice demonstrate increased insulin secretion in response to glucose (Moynihan et al. 2005
). Conversely, SIRT1-/- mice or their isolated islets show blunted insulin secretion (Bordone et al. 2006
). Both studies find that SIRT1 represses transcription of the mitochondrial uncoupling protein UCP-2 gene, which uncouples mitochondrial respiration from ATP production and reduces the proton gradient across the mitochondrial membrane. Thus, by blocking UCP-2 function, SIRT1 promotes more efficient energy generation. Indeed, BESTO islets demonstrate higher ATP levels (Moynihan et al. 2005
), while islets from SIRT1 knockout (KO) mice do not elevate ATP production in response to glucose (Bordone et al. 2006
). Interestingly, SIRT1-mediated repression of UCP-2 is alleviated by acute food deprivation (Bordone et al. 2006
), which may further dampen ATP synthesis and the insulin responsiveness of ß-cells during starvation. While SIRT1 protein level is not affected by this condition, there is a decrease in the NAD/NADH ratio, which may reduce SIRT1 activity in pancreas (Bordone et al. 2006
). The presence of UCP-2 in fasted animals may also ease the transition to metabolic activity after the next feeding and prevent hyperpolarization of the mitochondrial membrane and the corresponding production of reactive oxygen species. While these studies demonstrate that SIRT1 activity may be down-regulated in ß-cells during fasting, it is not known whether SIRT1 regulates insulin secretion during CR, or plays any role in pathologies demonstrating impaired insulin secretion.
Another study raises the possibility that SIRT1 promotes the survival of pancreatic ß-cells during oxidative stress (Kitamura et al. 2005
). In stressed ß-cells, the forkhead protein FOXO1 moves into the nucleus and activates the ß-cell transcription factors, NeuroD and MafA, and provides stress resistance. As described above, SIRT1 binds to and regulates forkhead transcription factors both negatively and positively (Brunet et al. 2004
; Motta et al. 2004
). Kitamura et al. (2005)
show that nuclear FOXO1 associates with SIRT1 in PML (promyelocytic leukemia) bodies in stressed cells. They suggest that SIRT1 deacetylates FOXO1 at that location to activate the protein and provide stress resistance (Accili and Arden 2004
). This process bears similarity to sir-2.1 in C. elegans discussed above, which functions as a coactivator of the DAF-16 protein after it translocates to the nucleus in oxidatively or heat stressed worms (Berdichevsky et al. 2006
).
Glucose homeostasis is maintained by the liver, in addition to pancreatic ß-cells, in response to changing nutrient conditions. During fasting, hepatocytes induce gluconeogenesis to supply other tissues with glucose. Several new studies have revealed that this nutrient response is under tight control of SIRT1 activity, providing another link between SIRT1 and metabolism. In cultured hepatocytes, SIRT1 interacts with and deacetylates nuclear FOXO1, promoting FOXO1-dependent transcription of hepatic gluconeogenic genes upon stress (Frescas et al. 2005
). In the liver, the transcriptional coactivator PGC-1
also drives expression of the gluconeogenic pathway. SIRT1 deacetylates and activates PGC-1
to coordinate the increase in expression of gluconeogenic genes with the repression of glycolytic genes during fasting (Rodgers et al. 2005
). However, in a neuronal cell line, overexpression of SIRT1 decreases the activity of PGC1-
and mitochondrial function (Nemoto et al. 2005
), suggesting that the relationship between SIRT1 and PGC-1
may be complex.
| SIRT1 and neuron function |
|---|
|
|
|---|
SIR2 orthologs can also protect against neuronal dysfunction due to polyglutamine toxicity in C. elegans and mammalian cells (Parker et al. 2005
). One study shows that neurotoxicity in worms is spared by the age-1 mutation, which reduces insulin-like signaling (Morley et al. 2002
), or in a transgenic strain overexpressing sir-2.1 (Parker et al. 2005
). Like the effects of the age-1 or sir-2.1 transgenes in extending lifespan, neuroprotection requires the forkhead protein DAF-16 (Parker et al. 2005
). As might be expected, polyglutamine toxicity is exacerbated in daf-16 or sir-2.1 mutants. The putative SIR2-activating polyphenol, resveratrol (Howitz et al. 2003
), also protects against cell death in striatal neurons with the Huntingtons Disease allele htt (109Q) (Parker et al. 2005
). Finally, ß-amyloid-induced death of microglia is spared by overexpression of SIRT1 or resveratrol treatment (J.Chen et al. 2005
). In toto, the above studies raise the possibility that activation of SIRT1 may be a novel strategy to protect against neurodegenerative diseases. We note, however, that the protective effect of SIRT1 may not be universal in all cell types, since SIRT1-/- mouse embryonic fibroblasts (MEFs) actually survive better in culture and bypass senescence (Chua et al. 2005
).
| SIRT1 and CR |
|---|
|
|
|---|
A more direct demonstration of the requirement of SIRT1 in CR involved placing SIRT1 KO mice on this diet (D.Chen et al. 2005
). Although the KO mice show changes in blood glucose, triglycerides, and IGF-1 similar to wild-type controls, there is a large difference in one interesting output of CR. Wild-type mice show a fivefold to 10-fold increase in physical activity, which has been observed previously and may represent a foraging instinct induced by food insufficiency, but KO mice do not display any increase in activity. SIRT1 KO mice move as well or better than wild type when challenged by other means; i.e., rotarod or treadmill. This study indicates the first requirement for SIRT1 for at least one phenotype triggered by mammalian CR.
| SIRT6 regulates DNA repair |
|---|
|
|
|---|
Recent work has provided insight into the diverse physiological functions of SIRT6 (Mostoslavsky et al. 2006
). SIRT6 KO mice display premature aging symptoms, including loss of subcutaneous fat and decreased bone density, and die within 4 wk after birth. These phenotypes contrast with those of SIRT1 KO animals, which are postnatal lethal on an inbred strain (Cheng et al. 2003
; McBurney et al. 2003
). Outbred SIRT1 KO animals can survive into adulthood, but demonstrate a severe phenotype, including small size, delayed bone mineralization, defective skeletal closure, delayed eyelid opening, and sterility (Cheng et al. 2003
; McBurney et al. 2003
; Lemieux et al. 2005
).
SIRT6 KO mice exhibit a deficiency in one specific form of DNA repair, the base excision repair (BER) (Mostoslavsky et al. 2006
). MEFs lacking SIRT6 demonstrate impaired proliferation and enhanced sensitivity to DNA-damaging agents. SIRT6 KO MEFs demonstrate genomic instability in the form of chromosomal translocations, fragments, gaps, and detached centromeres. These defects can be rescued by overexpression of the DNA polymerase involved in BER, Polß. Furthermore, SIRT6 KO MEFs exhibit normal cell cycle checkpoints, end-joining, and double-strand break DNA repair. How SIRT6 regulates BER is still unknown. One might hypothesize that this sirtuin ADP-ribosylates a substrate protein involved in BER, which could be a component of the repair machinery or the chromatin at the site of DNA damage.
SIRT6 KO mice also display interesting metabolic phenotypes: low levels of circulating IGF-1 and hypoglycemia that becomes progressively more severe with age (Mostoslavsky et al. 2006
). It will be interesting to know whether these metabolic changes are due to a direct role for SIRT6 in regulating IGF-1 and glucose homeostasis or are an indirect consequence of DNA damage that accumulates in these mutant mice.
| SIRT7 promotes rRNA transcription |
|---|
|
|
|---|
Recent work has shown that SIRT7 may regulate cellular growth and metabolism (Ford et al. 2006
). In the nucleolus, SIRT7 associates with rDNA and interacts with RNA polymerase I (Pol I). Overexpressing SIRT7 increases rRNA transcription and RNA inhibition of SIRT7 decreases transcription, showing that this sirtuin activates Pol I transcription (Ford et al. 2006
).
An NAD-dependent deacetylase activity has not been observed for SIRT7 (North et al. 2003
), but the amino acid residues that bind NAD in the conserved sirtuin core domain are required for SIRT7 activity (Ford et al. 2006
), suggesting a role for NAD-dependent regulation. SIRT7 thus appears to regulate cell growth and metabolism in response to changing metabolic conditions by driving ribosome biogenesis in dividing cells. It is interesting that both SIRT7, as an activator of rRNA transcription, and SIRT1, as an inhibitor of p53 and FOXO, have features that are progrowth and prosurvival for cells.
| Cytoplasmic sirtuins |
|---|
|
|
|---|
-cells (Imai et al. 2000| SIRT2 |
|---|
|
|
|---|
Cell culture studies demonstrate SIRT2 may be important in regulating mammalian cell cycle. SIRT2 protein levels increase during mitotic phase of the cell cycle and its overexpression delays mitosis (Dryden et al. 2003
). Consistent with the idea that SIRT2 may restrain the cell cycle, expression of this sirtuin is down-regulated in human gliomas, compared with normal brain samples (Hiratsuka et al. 2003
). SIRT2 colocalizes with chromatin during the G2/M transition, a period in which the nuclear membrane has broken down (Vaquero et al. 2006
). Both SIRT2 and Hst2 show a preference for deacetylating histone H4 at Lys16 in vitro, and SIRT2 KO mouse embryonic fibroblasts (MEFs) display hyperacetylated H4K16 during mitosis. Since SIRT1 also deacetylates H4K16, SIRT2 and SIRT1 may function redundantly, at least during the M phase of the cell cycle. SIRT2 may also regulate other phases of the cell cycle, since G1 is extended and S is shortened in SIRT2-/-MEFs.
| Mitochondrial sirtuinskey regulators of metabolism |
|---|
|
|
|---|
The mitochondrial localization of SIRT35 is especially intriguing because mitochondrial dysfunction is associated with mammalian aging and many diseases, including diabetes, neurodegenerative diseases, and cancer (Wallace 2005
). Do mitochondrial sirtuins regulate metabolism, the oxidative stress response, and ultimately, mammalian aging? It is important to note that although SIRT1 is not itself physically associated with mitochondria, as described above, it also impacts mitochondrial functions. Lifespan analysis of animals with varying SIRT35 level has not been performed; however, there is growing evidence linking mitochondrial sirtuins with regulating energy usage and even human lifespan.
| SIRT3 |
|---|
|
|
|---|
The biological functions of SIRT3 are beginning to emerge. SIRT3 is expressed in brown adipose tissue and induced by cold exposure (Shi et al. 2005
). Moreover, the deacetylase activity of SIRT3 is reported to be required for the induction of uncoupling protein 1 (UCP-1). SIRT3 also appears to regulate mitochondrial functions, as its overexpression increases respiration, while decreasing reactive oxygen species production (Shi et al. 2005
).
Two recent studies demonstrate that SIRT3 may regulate the activity of acetyl-CoA synthetase (AceCS) (Hallows et al. 2006
; Schwer et al. 2006
), representing a striking, conserved activity with the bacterial sirtuin, cobB (Tsang and Escalante-Semerena 1998
; Starai et al. 2002
). AceCS uses acetate, CoA, and ATP to form acetyl-CoA, which is an intermediate in the TCA cycle, and is also required for cholesterol and fatty acid synthesis. Acetylation of mitochondrial AceCS (AceCS2) inactivates the enzyme, whereas deacetylation by SIRT3 activates it. Interestingly, SIRT1 can deacetylate and activate the cytosolic form of AceCS (AceCS1). These data suggest that SIRT3 may play a role in regulating the entry of carbons from acetate into central metabolism. It will be important to assess the in vivo relevance of these findings using SIRT3-/- mice. In sum, SIRT3 may be especially important under conditions of energy limitationi.e., during fasting or CR to ensure full incorporation of dietary or ketone-derived acetate into metabolism.
In human population studies, polymorphisms within the SIRT3 gene have been linked to longevity. The G477T transversion, while not affecting the amino acid sequence, associates with survivalship of elderly males (Rose et al. 2003
) and may signify a haplotype promoting longevity. The same group found that a variable number of tandem repeats (VNTR) enhancer within SIRT3 also associates with lifespans >90 yr (Bellizzi et al. 2005
). These findings will need to be validated in larger samples, but suggest that the expression of SIRT3 may promote longevity in humans and raise the importance of performing lifespan experiments in mice that overexpress or lack SIRT3.
| SIRT4 |
|---|
|
|
|---|
-ketoglutarate, a TCA cycle intermediate. GDH-activating mutations cause hyperinsulinism in humans showing that this enzyme regulates insulin secretion by gating the flow of amino acids into central metabolism in ß-cells (Stanley et al. 1998
|
We note that the apparent down-regulation of SIRT4 during CR in ß-cells and liver goes against the expectation that sirtuin activity should increase during this dietary regimen. However, it is consistent with the observed reduction in the NAD/NADH ratio in liver of CR mice (Hagopian et al. 2003b
) and the observed increase in gluconeogenesis in this organ (Hagopian et al. 2003a
). We suggest that a shift from carbohydrates to fat as preferred energy source during CR may help drive down the NAD/ NADH ratio in these tissues and thus moderate these metabolic changes.
| SIRT5 |
|---|
|
|
|---|
| Summary and perspective |
|---|
|
|
|---|
While it may be years before we know whether sirtuins regulate mammalian lifespan, current data suggests that these proteins are regulated by diet and in turn, regulate multiple facets of physiology, making them interesting therapeutic targets for metabolic and neurodegenerative diseases (Fig. 4). Several important questions need to be resolved to improve our understanding of sirtuin biology and their therapeutic potential. First, what other functions can be ascribed to the SIRT17 proteins? We predict that like SIRT1, SIRT27 will have multiple targets and may affect many biologies. Second, how is sirtuin function regulated? Two known mechanisms of sirtuin regulation are (1) its protein induction during CR or fasting (Cohen et al. 2004
; Nisoli et al. 2005
; Rodgers et al. 2005
) and (2) regulation by metabolites NAD, NADH, and nicotinamide (Anderson et al. 2003a
, b
; Lin et al. 2004
). Third, are all seven sirtuins regulated in the same direction by CR in any given tissue? If the NAD/ NADH ratio (or nicotinamide concentration) is a primary determinant of regulation, it is possible that all seven sirtuins will be regulated similarly by CR in a given cell, since the NAD/NADH ratio has the potential to equilibrate throughout cellular compartments by shuttle systems. Another likely possibility is that the concentration of NAD and its metabolites are regulated compartmentally. For example, enzymes involved in NAD biosynthesis are found in the nucleus, peroxisome, Golgi apparatus, mitochondria, and cytoplasm (Yang et al. 2006
). Fourth, does the NAD/NADH ratio change in different directions depending on the tissue in response to CR? This possibility seems likely, since CR induces distinct metabolic changes in different tissues (e.g., activation of gluconeogenesis in liver and fat loss in white adipose tissue). Moreover, fasting decreases SIRT1 activity in the pancreas (Bordone et al. 2006
), while increasing its activity in the liver (Rodgers et al. 2005
). This last question is important, because if sirtuins are activated by CR in some tissues but repressed in others, genetically altered mice (i.e., SIRT knockout or overexpressed) or pharmacological interventions to activate or repress a sirtuin systemically (see below) may mimic CR in only a segmental fashion.
|
| Footnotes |
|---|
E-MAIL leng{at}mit.edu; FAX (617) 253-8699. ![]()
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1467506.
| References |
|---|
|
|
|---|
Anderson, R.M., Bitterman, K.J., Wood, J.G., Medvedik, O., and Sinclair, D.A. 2003a. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae . Nature 423: 181185.[CrossRef][Medline]
Anderson, R.M., Latorre-Esteves, M., Neves, A.R., Lavu, S., Medvedik, O., Taylor, C., Howitz, K.T., Santos, H., and Sinclair, D.A. 2003b. Yeast life-span extension by calorie restriction is independent of NAD fluctuation. Science 302: 21242126.
Araki, T., Sasaki, Y., and Milbrandt, J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 10101013.
Austad, S.N. 1989. Life extension by dietary restriction in the bowl and doily spider, Frontinella pyramitela . Exp. Gerontol. 24: 8392.[CrossRef][Medline]
Barzilai, N., Banerjee, S., Hawkins, M., Chen, W., and Rossetti, L. 1998. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101: 13531361.[Medline]
Bellizzi, D., Rose, G., Cavalcante, P., Covello, G., Dato, S., De Rango, F., Greco, V., Maggiolini, M., Feraco, E., and Mari, V., et al. 2005. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85: 258263.[CrossRef][Medline]
Berdichevsky, A., Viswanathan, M., Horvitz, H.R., and Guarente, L. 2006. C. elegans SIR-2.1 interacts with 1433 proteins to activate DAF-16 and extend life span. Cell 125: 11651177.[CrossRef][Medline]
Blander, G. and Guarente, L. 2004. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73: 417435.[CrossRef][Medline]
Bordone, L., Motta, M.C., Picard, F., Robinson, A., Jhala, U.S., Apfeld, J., McDonagh, T., Lemieux, M., McBurney, M., and Szilvasi, A., et al. 2006. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic ß cells. PLoS Biol. 4: 31.[CrossRef]
Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran, H., Ross, S.E., Mostoslavsky, R., and Cohen, H.Y., et al. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 20112015.
Chen, D., Steele, A.D., Lindquist, S., and Guarente, L. 2005. Increase in activity during calorie restriction requires Sirt1. Science 310: 1641.
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.F., Kwon, H., Yi, S., Mucke, L., and Gan, L. 2005. SIRT1 protects against microglia-dependent amyloid-ß toxicity through inhibiting NF-
B signaling. J. Biol. Chem. 280: 4036440374.
Cheng, H.L., Mostoslavsky, R., Saito, S., Manis, J.P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F.W., and Chua, K.F. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. 100: 1079410799.
Chua, K.F., Mostoslavsky, R., Lombard, D.B., Pang, W.W., Saito, S., Franco, S., Kaushal, D., Cheng, H.L., Fischer, M.R., and Stokes, N., et al. 2005. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab. 2: 6776.[CrossRef][Medline]
Cohen, H.Y., Miller, C., Bitterman, K.J., Wall, N.R., Hekking, B., Kessler, B., Howitz, K.T., Gorospe, M., de Cabo, R., and Sinclair, D.A. 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390392.
Comfort, A. 1963. Effect of delayed and resumed growth on the longevity of a fish (Lebistes reticulatus, Peters) in captivity. Gerontologia 49: 150155.[Medline]
Dhahbi, J.M., Mote, P.L., Wingo, J., Rowley, B.C., Cao, S.X., Walford, R.L., and Spindler, S.R. 2001. Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech. Ageing Dev. 122: 10331048.[CrossRef][Medline]
Dryden, S.C., Nahhas, F.A., Nowak, J.E., Goustin, A.S., and Tainsky, M.A. 2003. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23: 31733185.
Duan, W. and Mattson, M.P. 1999. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's dis